Abstract
Copper (Cu) and zinc (Zn) imbalances are common in dialysis patients. This study aimed to investigate the relationship between the blood Cu/Zn ratio and anemia in patients undergoing maintenance hemodialysis (MHD) treatment. This cross-sectional study included patients undergoing MHD at our center in September 2019. Clinical and demographic data and blood samples were collected before the hemodialysis sessions, and the blood levels of Zn and Cu were measured by inductively coupled plasma mass spectrometry. Multivariable linear and binary logistic regression analyses were performed to study the relationship between blood Cu/Zn ratio and anemia. A total of 144 MHD patients were enrolled in this study. The patients had a mean age of 64.33 ± 13.39 years, a median dialysis vintage of 33.50 (16.25–57.50) months, with 66 being females (45.8%). The median blood Cu/Zn ratio was 15.55 (interquartile range: 12.47–20.31). Anemia was present in 99 patients (68.8%). Groups with higher hemoglobin levels had decreased blood Cu/Zn ratios (p < 0.05). After adjustments for confounding factors, higher blood Cu/Zn ratios were independently associated with lower hemoglobin levels and anemia in MHD patients based on multivariate linear and multivariate binary logistic regression, respectively, in different models. Our study found that the blood Cu/Zn ratio is independently associated with anemia in MHD patients, but prospective multicenter studies with larger sample sizes are still needed to determine the appropriate cutoff values for blood zinc, blood copper, and blood Cu/Zn levels in this patient population.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
References
Ma JZ, Ebben J, Xia H, Collins AJ (1999) Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10:610–619
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61. https://doi.org/10.1016/s0272-6386(96)90130-4
Lee KH, Ho Y, Tarng DC (2021) Iron Therapy in Chronic Kidney Disease: Days of Future Past. Int J Mol Sci 22(3):1008. https://doi.org/10.3390/ijms22031008
Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, Isaac H, Bhandari S (2017) Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrol 18:345. https://doi.org/10.1186/s12882-017-0688-1
Zuo L, Wang M, Hou F, Yan Y, Chen N, Qian J, Wang M, Bieber B, Pisoni RL, Robinson BM, Anand S (2016) Anemia Management in the China Dialysis Outcomes and Practice Patterns Study. Blood Purif 42:33–43. https://doi.org/10.1159/000442741
Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J, Alberta Kidney Disease N (2009) Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med 7:25. https://doi.org/10.1186/1741-7015-7-25
Fukushima T, Horike H, Fujiki S, Kitada S, Sasaki T, Kashihara N (2009) Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients. Ther Apher Dial 13:213–219. https://doi.org/10.1111/j.1744-9987.2009.00656.x
Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M (2015) Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis. Nutrients 7:3783–3795. https://doi.org/10.3390/nu7053783
Nishime K, Kondo M, Saito K, Miyawaki H, Nakagawa T (2020) Zinc Burden Evokes Copper Deficiency in the Hypoalbuminemic Hemodialysis Patients. Nutrients 12(2):577. https://doi.org/10.3390/nu12020577
Myint ZW, Oo TH, Thein KZ, Tun AM, Saeed H (2018) Copper deficiency anemia: review article. Ann Hematol 97:1527–1534. https://doi.org/10.1007/s00277-018-3407-5
Osredkar J, Sustar N (2011) Copper and zinc, biological role and significance of copper/zinc imbalance. J Clin Toxicol. https://doi.org/10.4172/2161-0495.S3-001
Malavolta M, Giacconi R, Piacenza F, Santarelli L, Cipriano C, Costarelli L, Tesei S, Pierpaoli S, Basso A, Galeazzi R, Lattanzio F, Mocchegiani E (2010) Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology 11:309–319. https://doi.org/10.1007/s10522-009-9251-1
Canellas CG, Carvalho SM, Anjos MJ, Lopes RT (2012) Determination of Cu/Zn and Fe in human serum of patients with sickle cell anemia using radiation synchrotron. Appl Radiat Isot 70:1277–1280. https://doi.org/10.1016/j.apradiso.2011.12.028
Liu Y, Zheng Y, Wang L, Zhong X, Qin D, Chen W, Tan R, Liu Y (2020) Lower Levels of Blood Zinc Associated with Intradialytic Hypertension in Maintenance Hemodialysis Patients. Biol Trace Elem Res. https://doi.org/10.1007/s12011-020-02385-4
Bahi GA, Boyvin L, Meite S, M’Boh GM, Yeo K, N’Guessan KR, Bidie AD, Djaman AJ (2017) Assessments of serum copper and zinc concentration, and the Cu/Zn ratio determination in patients with multidrug resistant pulmonary tuberculosis (MDR-TB) in Cote d’Ivoire. BMC Infect Dis 17:257. https://doi.org/10.1186/s12879-017-2343-7
Braun LA, Rosenfeldt F (2013) Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy. Int J Clin Pract 67:717–725. https://doi.org/10.1111/ijcp.12040
Foote JW, Hinks LJ (1988) Zinc absorption in haemodialysis patients. Ann Clin Biochem 25(Pt 4):398–402. https://doi.org/10.1177/000456328802500413
Rucker D, Thadhani R, Tonelli M (2010) Trace element status in hemodialysis patients. Semin Dial 23:389–395. https://doi.org/10.1111/j.1525-139X.2010.00746.x
Stewart-Knox BJ, Simpson EE, Parr H, Rae G, Polito A, Intorre F, Meunier N, Andriollo-Sanchez M, O’Connor JM, Coudray C, Strain JJ (2005) Zinc status and taste acuity in older Europeans: the ZENITH study. Eur J Clin Nutr 59(Suppl 2):S31-36. https://doi.org/10.1038/sj.ejcn.1602295
Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) 8:34. https://doi.org/10.1186/1743-7075-8-34
Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ (1992) Treatment of Wilson’s disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 120:380–386
Osawa M, Yamaguchi T, Nakamura Y, Kaneko S, Onodera M, Sawada K, Jegalian A, Wu H, Nakauchi H, Iwama A (2002) Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis. Blood 100:2769–2777. https://doi.org/10.1182/blood-2002-01-0182
Garcon L, Lacout C, Svinartchouk F, Le Couedic JP, Villeval JL, Vainchenker W, Dumenil D (2005) Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood 105:1448–1455. https://doi.org/10.1182/blood-2003-11-4068
Baltaci AK, Mogulkoc R, Baltaci SB (2019) Review: The role of zinc in the endocrine system. Pak J Pharm Sci 32:231–239
McClain C, Morris P, Hennig B (1995) Zinc and endothelial function. Nutrition 11:117–120
Polenakovic M, Sikole A (1996) Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol 7:1178–1182
Reina de la Torre ML, Navarro-Alarcon M, del Moral LM, GdlSH L, Palomares-Bayo M, Oliveras Lopez MJ, Blanca Herrera RM, Agil A (2014) Serum Zn levels and Cu/Zn ratios worsen in hemodialysis patients, implying increased cardiovascular risk: a 2-year longitudinal study. Biol Trace Elem Res 158:129–135. https://doi.org/10.1007/s12011-014-9921-y
Escobedo-Monge MF, Barrado E, Alonso Vicente C, Escobedo-Monge MA, Torres-Hinojal MC, Marugan-Miguelsanz JM, Redondo Del Rio MP (2020) Copper and Copper/Zinc Ratio in a Series of Cystic Fibrosis Patients. Nutrients 12(11):3344. https://doi.org/10.3390/nu12113344
Schneider T, Caviezel D, Ayata CK, Kiss C, Niess JH, Hruz P (2020) The Copper/Zinc Ratio Correlates With Markers of Disease Activity in Patients With Inflammatory Bowel Disease. Crohn’s Colitis 360 2:otaa001. https://doi.org/10.1093/crocol/otaa001
Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL (2011) Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem 44:275–280. https://doi.org/10.1016/j.clinbiochem.2010.12.017
Hambidge KM, Krebs NF (2007) Zinc deficiency: a special challenge. J Nutr 137:1101–1105. https://doi.org/10.1093/jn/137.4.1101
Ikee R, Tsunoda M, Sasaki N, Sato N, Hashimoto N (2013) Clinical factors associated with serum copper levels and potential effect of sevelamer in hemodialysis patients. Int Urol Nephrol 45:839–845. https://doi.org/10.1007/s11255-012-0211-3
Shalaby MR, Waage A, Aarden L, Espevik T (1989) Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 53:488–498. https://doi.org/10.1016/0090-1229(89)90010-x
Schroeder JJ, Cousins RJ (1990) Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci U S A 87:3137–3141. https://doi.org/10.1073/pnas.87.8.3137
Garla R, Kango P, Gill NK, Garg ML (2017) Induction of Metallothionein in Rat Liver by Zinc Exposure: A Dose and Time Dependent Study. Protein J 36:433–442. https://doi.org/10.1007/s10930-017-9737-7
Schoenberger SG, Sutherland CM, Robinson AE (1988) Breast neoplasms: duplex sonographic imaging as an adjunct in diagnosis. Radiology 168:665–668. https://doi.org/10.1148/radiology.168.3.2841719
Jarosz M, Olbert M, Wyszogrodzka G, Mlyniec K, Librowski T (2017) Antioxidant and anti-inflammatory effects of zinc Zinc-dependent NF-kappaB signaling. Inflammopharmacology 25:11–24. https://doi.org/10.1007/s10787-017-0309-4
Foster M, Samman S (2012) Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients 4:676–694. https://doi.org/10.3390/nu4070676
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig 113:1271–1276. https://doi.org/10.1172/JCI20945
Coyne DW, Fleming R (2021) Will Targeting Interleukin-6 in the Anemia of CKD Change Our Treatment Paradigm? J Am Soc Nephrol 32:6–8. https://doi.org/10.1681/ASN.2020101476
Okamoto T, Hatakeyama S, Konishi S, Okita K, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C (2020) Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study. Ther Apher Dial 24:568–577. https://doi.org/10.1111/1744-9987.13461
Kadoya H, Uchida A, Kashihara N (2016) A Case of Copper Deficiency-Induced Pancytopenia With Maintenance Hemodialysis Outpatient Treated With Polaprezinc. Ther Apher Dial 20:422–423. https://doi.org/10.1111/1744-9987.12398
Illing AC, Shawki A, Cunningham CL, Mackenzie B (2012) Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. J Biol Chem 287:30485–30496. https://doi.org/10.1074/jbc.M112.364208
Guo CH, Wang CL (2013) Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci 10:79–89. https://doi.org/10.7150/ijms.5291
Acknowledgements
The authors are thankful to all nurses in the hemodialysis center of Guangzhou Red Cross Hospital, Jinan University. We specially thank Shilin Xu, B.S.Nurse, because all the laboratory data in the study derived from the electronic management system for blood purification center (Hope®, software) are developed by him, which can import the laboratory test results according to the patients’ IDs included in the study.
Funding
This research was supported by 1 grant from the Science and Technology Planning Project of Guangdong Province, 2017B090904027, and 1 grant from the Guangzhou Clinically Characteristic Technology Project No. 2019TS60.
Author information
Authors and Affiliations
Contributions
S.Z contributed to the study design, partial data collection, and drafting of the manuscript; M.L was involved in the analysis and interpretation of the data; Y.L contributed to the study design; S.X and J.Q collected data and blood samples in every MHD patients; X.Z, D.Q, R.T, and Y.L were involved in the study design and critical revision of the manuscript for important intellectual content; and D.Q finally approved the submission of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This study (including all protocols) was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Guangzhou Red Cross Hospital, Jinan University Hospital (license code: 2019–235-01).
Consent to Participate
Written informed consent was obtained from the individual or guardian participant.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zuo, S., Liu, M., Liu, Y. et al. Association Between the Blood Copper-Zinc (Cu/Zn) Ratio and Anemia in Patients Undergoing Maintenance Hemodialysis. Biol Trace Elem Res 200, 2629–2638 (2022). https://doi.org/10.1007/s12011-021-02888-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-021-02888-8